04:10 PM EST, 11/24/2025 (MT Newswires) -- Christine Fox, Executive Vice President, Head of US Commercial, on November 20, 2025, sold 28,229 shares in Teva Pharmaceutical Industries ( TEVA ) for $699,523. Following the Form 4 filing with the SEC, Fox has control over a total of 63,647 ordinary shares of the company, with 63,647 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000119312525293655/xslF345X05/ownership.xml